APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Drug and Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pet Drug and Vaccine Market Analysis and Forecast 2026-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchPet Drug and Vaccine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Drug and Vaccine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Pet Drug and Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Drug and Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Drug and Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Pet Drug and Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pet Drug and Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pet Drug and Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pet Drug and Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pet Drug and Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pet Drug and Vaccine include Boehringer Ingelheim, Ceva, Dechra Veterinary Products, Elanco Animal Health, Meiji, Merck Animal Health, Ouro Fino Saude, Parnell and Vetoquinol, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pet Drug and Vaccine, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pet Drug and Vaccine, also provides the revenue of main regions and countries. Of the upcoming market potential for Pet Drug and Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pet Drug and Vaccine revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pet Drug and Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pet Drug and Vaccine revenue, projected growth trends, production technology, application and end-user industry.

Pet Drug and Vaccine Segment by Company

Boehringer Ingelheim

Ceva

Dechra Veterinary Products

Elanco Animal Health

Meiji

Merck Animal Health

Ouro Fino Saude

Parnell

Vetoquinol

Virbac

Zoetis

Pet Drug and Vaccine Segment by Type

Drugs

Vaccine

Pet Drug and Vaccine Segment by Application

Dogs

Cats

Other

Pet Drug and Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Drug and Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Drug and Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Drug and Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pet Drug and Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pet Drug and Vaccine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Drug and Vaccine revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pet Drug and Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Drugs Major Player Table 3. Vaccine Major Player Table 4. Global Pet Drug and Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Dogs Major Player Table 6. Cats Major Player Table 7. Other Major Player Table 8. Pet Drug and Vaccine Industry Trends Table 9. Pet Drug and Vaccine Industry Drivers Table 10. Pet Drug and Vaccine Industry Opportunities and Challenges Table 11. Pet Drug and Vaccine Industry Restraints Table 12. Global Pet Drug and Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Pet Drug and Vaccine Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Pet Drug and Vaccine Market Share by Region (2021-2026) Table 15. Global Pet Drug and Vaccine Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Pet Drug and Vaccine Market Share by Region (2027-2032) Table 17. Global Pet Drug and Vaccine Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Pet Drug and Vaccine Revenue Market Share by Players (2021-2026) Table 19. Global Pet Drug and Vaccine Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pet Drug and Vaccine Key Players Headquarters & Area Served Table 21. Global Pet Drug and Vaccine Players, Product Type & Application Table 22. Global Pet Drug and Vaccine Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Pet Drug and Vaccine by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Pet Drug and Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pet Drug and Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Pet Drug and Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Pet Drug and Vaccine Revenue Market Share by Type (2021-2026) Table 29. Global Pet Drug and Vaccine Revenue Market Share by Type (2027-2032) Table 30. Global Pet Drug and Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pet Drug and Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Pet Drug and Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Pet Drug and Vaccine Revenue Market Share by Application (2021-2026) Table 34. Global Pet Drug and Vaccine Revenue Market Share by Application (2027-2032) Table 35. Boehringer Ingelheim Company Information Table 36. Boehringer Ingelheim Business Overview Table 37. Boehringer Ingelheim Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Boehringer Ingelheim Pet Drug and Vaccine Product Portfolio Table 39. Boehringer Ingelheim Recent Development Table 40. Ceva Company Information Table 41. Ceva Business Overview Table 42. Ceva Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Ceva Pet Drug and Vaccine Product Portfolio Table 44. Ceva Recent Development Table 45. Dechra Veterinary Products Company Information Table 46. Dechra Veterinary Products Business Overview Table 47. Dechra Veterinary Products Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Dechra Veterinary Products Pet Drug and Vaccine Product Portfolio Table 49. Dechra Veterinary Products Recent Development Table 50. Elanco Animal Health Company Information Table 51. Elanco Animal Health Business Overview Table 52. Elanco Animal Health Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Elanco Animal Health Pet Drug and Vaccine Product Portfolio Table 54. Elanco Animal Health Recent Development Table 55. Meiji Company Information Table 56. Meiji Business Overview Table 57. Meiji Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Meiji Pet Drug and Vaccine Product Portfolio Table 59. Meiji Recent Development Table 60. Merck Animal Health Company Information Table 61. Merck Animal Health Business Overview Table 62. Merck Animal Health Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Merck Animal Health Pet Drug and Vaccine Product Portfolio Table 64. Merck Animal Health Recent Development Table 65. Ouro Fino Saude Company Information Table 66. Ouro Fino Saude Business Overview Table 67. Ouro Fino Saude Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Ouro Fino Saude Pet Drug and Vaccine Product Portfolio Table 69. Ouro Fino Saude Recent Development Table 70. Parnell Company Information Table 71. Parnell Business Overview Table 72. Parnell Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Parnell Pet Drug and Vaccine Product Portfolio Table 74. Parnell Recent Development Table 75. Vetoquinol Company Information Table 76. Vetoquinol Business Overview Table 77. Vetoquinol Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Vetoquinol Pet Drug and Vaccine Product Portfolio Table 79. Vetoquinol Recent Development Table 80. Virbac Company Information Table 81. Virbac Business Overview Table 82. Virbac Pet Drug and Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Virbac Pet Drug and Vaccine Product Portfolio Table 84. Virbac Recent Development Table 85. Zoetis Company Information Table 86. Zoetis Business Overview Table 87. Zoetis Pet Drug and Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Zoetis Pet Drug and Vaccine Product Portfolio Table 89. Zoetis Recent Development Table 90. North America Pet Drug and Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 91. North America Pet Drug and Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 92. North America Pet Drug and Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Pet Drug and Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Pet Drug and Vaccine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Pet Drug and Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Pet Drug and Vaccine Revenue by Country (US$ Million) & (2027-2032) Table 97. Europe Pet Drug and Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Pet Drug and Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Pet Drug and Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 100. Europe Pet Drug and Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 101. Europe Pet Drug and Vaccine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Pet Drug and Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 103. Europe Pet Drug and Vaccine Revenue by Country (US$ Million) & (2027-2032) Table 104. China Pet Drug and Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 105. China Pet Drug and Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 106. China Pet Drug and Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 107. China Pet Drug and Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Pet Drug and Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 109. Asia Pet Drug and Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 110. Asia Pet Drug and Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 111. Asia Pet Drug and Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 112. Asia Pet Drug and Vaccine Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Pet Drug and Vaccine Revenue by Region (US$ Million) & (2021-2026) Table 114. Asia Pet Drug and Vaccine Revenue by Region (US$ Million) & (2027-2032) Table 115. SAMEA Pet Drug and Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 116. SAMEA Pet Drug and Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 117. SAMEA Pet Drug and Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 118. SAMEA Pet Drug and Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 119. SAMEA Pet Drug and Vaccine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. SAMEA Pet Drug and Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 121. SAMEA Pet Drug and Vaccine Revenue by Country (US$ Million) & (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Pet Drug and Vaccine Image Figure 2. Global Pet Drug and Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Drug and Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Drugs Image Figure 5. Vaccine Image Figure 6. Global Pet Drug and Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pet Drug and Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Dogs Image Figure 9. Cats Image Figure 10. Other Image Figure 11. Global Pet Drug and Vaccine Market Size (US$ Million) & (2021-2032) Figure 12. Global Pet Drug and Vaccine Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pet Drug and Vaccine Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Pet Drug and Vaccine Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Pet Drug and Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pet Drug and Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Pet Drug and Vaccine Revenue Market Share by Type (2021-2032) Figure 19. Global Pet Drug and Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pet Drug and Vaccine Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Pet Drug and Vaccine Revenue Market Share by Application (2021-2032) Figure 22. North America Pet Drug and Vaccine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Pet Drug and Vaccine Revenue Share by Type (2021-2032) Figure 24. North America Pet Drug and Vaccine Revenue Share by Application (2021-2032) Figure 25. North America Pet Drug and Vaccine Revenue Share by Country (2021-2032) Figure 26. United States Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Pet Drug and Vaccine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Pet Drug and Vaccine Revenue Share by Type (2021-2032) Figure 31. Europe Pet Drug and Vaccine Revenue Share by Application (2021-2032) Figure 32. Europe Pet Drug and Vaccine Revenue Share by Country (2021-2032) Figure 33. Germany Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Pet Drug and Vaccine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Pet Drug and Vaccine Revenue Share by Type (2021-2032) Figure 43. China Pet Drug and Vaccine Revenue Share by Application (2021-2032) Figure 44. Asia Pet Drug and Vaccine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Pet Drug and Vaccine Revenue Share by Type (2021-2032) Figure 46. Asia Pet Drug and Vaccine Revenue Share by Application (2021-2032) Figure 47. Asia Pet Drug and Vaccine Revenue Share by Region (2021-2032) Figure 48. Japan Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Pet Drug and Vaccine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Pet Drug and Vaccine Revenue Share by Type (2021-2032) Figure 56. SAMEA Pet Drug and Vaccine Revenue Share by Application (2021-2032) Figure 57. SAMEA Pet Drug and Vaccine Revenue Share by Country (2021-2032) Figure 58. Brazil Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Pet Drug and Vaccine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Drugs
  • Vaccine
Applications
  • Dogs
  • Cats
  • Other
Companies covered
  • Boehringer Ingelheim
  • Ceva
  • Dechra Veterinary Products
  • Elanco Animal Health
  • Meiji
  • Merck Animal Health
  • Ouro Fino Saude
  • Parnell
  • Vetoquinol
  • Virbac
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pet Drug and Vaccine Market by Type
  3. 1.2.1 Global Pet Drug and Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Drugs
  5. 1.2.3 Vaccine
  6. 1.3 Pet Drug and Vaccine Market by Application
  7. 1.3.1 Global Pet Drug and Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Dogs
  9. 1.3.3 Cats
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pet Drug and Vaccine Market Dynamics
  1. 2.1 Pet Drug and Vaccine Industry Trends
  2. 2.2 Pet Drug and Vaccine Industry Drivers
  3. 2.3 Pet Drug and Vaccine Industry Opportunities and Challenges
  4. 2.4 Pet Drug and Vaccine Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pet Drug and Vaccine Market Perspective (2021-2032)
  2. 3.2 Global Pet Drug and Vaccine Growth Trends by Region
  3. 3.2.1 Global Pet Drug and Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pet Drug and Vaccine Market Size by Region (2021-2026)
  5. 3.2.3 Global Pet Drug and Vaccine Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pet Drug and Vaccine Revenue by Players
  2. 4.1.1 Global Pet Drug and Vaccine Revenue by Players (2021-2026)
  3. 4.1.2 Global Pet Drug and Vaccine Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pet Drug and Vaccine Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pet Drug and Vaccine Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pet Drug and Vaccine Key Players Headquarters & Area Served
  7. 4.4 Global Pet Drug and Vaccine Players, Product Type & Application
  8. 4.5 Global Pet Drug and Vaccine Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pet Drug and Vaccine Market CR5 and HHI
  11. 4.6.3 2025 Pet Drug and Vaccine Tier 1, Tier 2, and Tier 3
5 Pet Drug and Vaccine Market Size by Type
  1. 5.1 Global Pet Drug and Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pet Drug and Vaccine Revenue by Type (2021-2032)
  3. 5.3 Global Pet Drug and Vaccine Revenue Market Share by Type (2021-2032)
6 Pet Drug and Vaccine Market Size by Application
  1. 6.1 Global Pet Drug and Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pet Drug and Vaccine Revenue by Application (2021-2032)
  3. 6.3 Global Pet Drug and Vaccine Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Boehringer Ingelheim
  2. 7.1.1 Boehringer Ingelheim Company Information
  3. 7.1.2 Boehringer Ingelheim Business Overview
  4. 7.1.3 Boehringer Ingelheim Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Boehringer Ingelheim Pet Drug and Vaccine Product Portfolio
  6. 7.1.5 Boehringer Ingelheim Recent Developments
  7. 7.2 Ceva
  8. 7.2.1 Ceva Company Information
  9. 7.2.2 Ceva Business Overview
  10. 7.2.3 Ceva Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Ceva Pet Drug and Vaccine Product Portfolio
  12. 7.2.5 Ceva Recent Developments
  13. 7.3 Dechra Veterinary Products
  14. 7.3.1 Dechra Veterinary Products Company Information
  15. 7.3.2 Dechra Veterinary Products Business Overview
  16. 7.3.3 Dechra Veterinary Products Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Dechra Veterinary Products Pet Drug and Vaccine Product Portfolio
  18. 7.3.5 Dechra Veterinary Products Recent Developments
  19. 7.4 Elanco Animal Health
  20. 7.4.1 Elanco Animal Health Company Information
  21. 7.4.2 Elanco Animal Health Business Overview
  22. 7.4.3 Elanco Animal Health Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Elanco Animal Health Pet Drug and Vaccine Product Portfolio
  24. 7.4.5 Elanco Animal Health Recent Developments
  25. 7.5 Meiji
  26. 7.5.1 Meiji Company Information
  27. 7.5.2 Meiji Business Overview
  28. 7.5.3 Meiji Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Meiji Pet Drug and Vaccine Product Portfolio
  30. 7.5.5 Meiji Recent Developments
  31. 7.6 Merck Animal Health
  32. 7.6.1 Merck Animal Health Company Information
  33. 7.6.2 Merck Animal Health Business Overview
  34. 7.6.3 Merck Animal Health Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Merck Animal Health Pet Drug and Vaccine Product Portfolio
  36. 7.6.5 Merck Animal Health Recent Developments
  37. 7.7 Ouro Fino Saude
  38. 7.7.1 Ouro Fino Saude Company Information
  39. 7.7.2 Ouro Fino Saude Business Overview
  40. 7.7.3 Ouro Fino Saude Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Ouro Fino Saude Pet Drug and Vaccine Product Portfolio
  42. 7.7.5 Ouro Fino Saude Recent Developments
  43. 7.8 Parnell
  44. 7.8.1 Parnell Company Information
  45. 7.8.2 Parnell Business Overview
  46. 7.8.3 Parnell Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Parnell Pet Drug and Vaccine Product Portfolio
  48. 7.8.5 Parnell Recent Developments
  49. 7.9 Vetoquinol
  50. 7.9.1 Vetoquinol Company Information
  51. 7.9.2 Vetoquinol Business Overview
  52. 7.9.3 Vetoquinol Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Vetoquinol Pet Drug and Vaccine Product Portfolio
  54. 7.9.5 Vetoquinol Recent Developments
  55. 7.10 Virbac
  56. 7.10.1 Virbac Company Information
  57. 7.10.2 Virbac Business Overview
  58. 7.10.3 Virbac Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Virbac Pet Drug and Vaccine Product Portfolio
  60. 7.10.5 Virbac Recent Developments
  61. 7.11 Zoetis
  62. 7.11.1 Zoetis Company Information
  63. 7.11.2 Zoetis Business Overview
  64. 7.11.3 Zoetis Pet Drug and Vaccine Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Zoetis Pet Drug and Vaccine Product Portfolio
  66. 7.11.5 Zoetis Recent Developments
8 North America
  1. 8.1 North America Pet Drug and Vaccine Revenue (2021-2032)
  2. 8.2 North America Pet Drug and Vaccine Revenue by Type (2021-2032)
  3. 8.2.1 North America Pet Drug and Vaccine Revenue by Type (2021-2026)
  4. 8.2.2 North America Pet Drug and Vaccine Revenue by Type (2027-2032)
  5. 8.3 North America Pet Drug and Vaccine Revenue Share by Type (2021-2032)
  6. 8.4 North America Pet Drug and Vaccine Revenue by Application (2021-2032)
  7. 8.4.1 North America Pet Drug and Vaccine Revenue by Application (2021-2026)
  8. 8.4.2 North America Pet Drug and Vaccine Revenue by Application (2027-2032)
  9. 8.5 North America Pet Drug and Vaccine Revenue Share by Application (2021-2032)
  10. 8.6 North America Pet Drug and Vaccine Revenue by Country
  11. 8.6.1 North America Pet Drug and Vaccine Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pet Drug and Vaccine Revenue by Country (2021-2026)
  13. 8.6.3 North America Pet Drug and Vaccine Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Pet Drug and Vaccine Revenue (2021-2032)
  2. 9.2 Europe Pet Drug and Vaccine Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pet Drug and Vaccine Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pet Drug and Vaccine Revenue by Type (2027-2032)
  5. 9.3 Europe Pet Drug and Vaccine Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pet Drug and Vaccine Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pet Drug and Vaccine Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pet Drug and Vaccine Revenue by Application (2027-2032)
  9. 9.5 Europe Pet Drug and Vaccine Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pet Drug and Vaccine Revenue by Country
  11. 9.6.1 Europe Pet Drug and Vaccine Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pet Drug and Vaccine Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pet Drug and Vaccine Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Pet Drug and Vaccine Revenue (2021-2032)
  2. 10.2 China Pet Drug and Vaccine Revenue by Type (2021-2032)
  3. 10.2.1 China Pet Drug and Vaccine Revenue by Type (2021-2026)
  4. 10.2.2 China Pet Drug and Vaccine Revenue by Type (2027-2032)
  5. 10.3 China Pet Drug and Vaccine Revenue Share by Type (2021-2032)
  6. 10.4 China Pet Drug and Vaccine Revenue by Application (2021-2032)
  7. 10.4.1 China Pet Drug and Vaccine Revenue by Application (2021-2026)
  8. 10.4.2 China Pet Drug and Vaccine Revenue by Application (2027-2032)
  9. 10.5 China Pet Drug and Vaccine Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pet Drug and Vaccine Revenue (2021-2032)
  2. 11.2 Asia Pet Drug and Vaccine Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pet Drug and Vaccine Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pet Drug and Vaccine Revenue by Type (2027-2032)
  5. 11.3 Asia Pet Drug and Vaccine Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pet Drug and Vaccine Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pet Drug and Vaccine Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pet Drug and Vaccine Revenue by Application (2027-2032)
  9. 11.5 Asia Pet Drug and Vaccine Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pet Drug and Vaccine Revenue by Country
  11. 11.6.1 Asia Pet Drug and Vaccine Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pet Drug and Vaccine Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pet Drug and Vaccine Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pet Drug and Vaccine Revenue (2021-2032)
  2. 12.2 SAMEA Pet Drug and Vaccine Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pet Drug and Vaccine Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pet Drug and Vaccine Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pet Drug and Vaccine Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pet Drug and Vaccine Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pet Drug and Vaccine Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pet Drug and Vaccine Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pet Drug and Vaccine Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pet Drug and Vaccine Revenue by Country
  11. 12.6.1 SAMEA Pet Drug and Vaccine Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pet Drug and Vaccine Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pet Drug and Vaccine Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst